Meloxicam Tablet
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Meloxicam Tablet, covering 2014-07-08 to 2023-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis [Phase 3]